Dr Marcia Philbin starts as Chief Executive of the Faculty of Pharmaceutical Medicine

Posted on: Wednesday 7 August 2019

Dr Marcia Philbin

The Faculty of Pharmaceutical Medicine (FPM) welcomes Dr Marcia Philbin PhD CChem FRSC MAPM as its new Chief Executive. Dr Philbin was previously the Assistant Director for Research and Policy at the Royal College of Paediatrics and Child Health. She brings a wealth of experience in research and policy development, as well as project management, gained in the public and private sectors.

FPM is a professional membership organisation and standard‐setting body, with 1,500 members who are practising or retired pharmaceutical physicians or those with a professional interest in the speciality. FPM’s mission is to advance the science and practice of pharmaceutical medicine by working to develop and maintain competence, ethics and integrity and the highest professional standards in the specialty for the benefit of the public.

Dr Philbin said:
“I am delighted and excited to be joining the Faculty of Pharmaceutical Medicine, which celebrates its 30th anniversary in 2019. I am looking forward to working with the President, trustees, members and staff to build on the successes that have been achieved in the last thirty years. In particular, I look forward to leading on the implementation of the strategic plan, which will be focused on ensuring that FPM continues to grow as an influential and engaging professional body. Pharmaceutical medicine is a dynamic and exciting area, and FPM has an important role to play in promoting and growing this essential medical discipline, as well as undertaking activities to support and develop the professionalism of its members.”

Professor Tim Higenbottam, President of the Faculty of Pharmaceutical Medicine, said:
“It is wonderful to welcome Marcia to the FPM as our Chief Executive. We are embarking on a period of change that will bring greater support to our members. The life sciences industries are entering a period of exciting opportunities. Marcia brings her powerful scientific background and her governance experience to support and guide us through our transitions.”